Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 17/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 14/20 | 0.60 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8204244 | 0.94 | PTGS1 (0.51) | PTGS2PTGS1 | |
| SCHEMBL6520729 | 0.86 | PTGS2 (0.42) | PTGS2PTGS1 | |
| SCHEMBL8637642 | 0.84 | PTGS1 (0.46) | PTGS2PTGS1 | |
| SCHEMBL8640282 | 0.84 | PTGS1 (0.53) | PTGS2PTGS1 | |
| SCHEMBL8163016 | 0.82 | PTGS2 (0.41) | PTGS2PTGS1PDPK1 | |
| SCHEMBL8689002 | 0.81 | PTGS1 (0.55) | PTGS2PTGS1 | |
| SCHEMBL8619696 | 0.81 | PTGS2 (0.45) | PTGS2PTGS1PDPK1 | |
| Benzenesulfonamide SCHEMBL7773919 | 0.80 | PTGS2 (0.68) | PTGS2PTGS1PDPK1 | |
| SCHEMBL6513051 | 0.80 | KAT6A (0.40) | PTGS2PTGS1PDPK1 | |
| Benzenesulfonamide SCHEMBL7113357 | 0.80 | PTGS2 (0.59) | PTGS2PTGS1PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1299122-A2 | COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN | Pharmacia Corporation (US) | 2003-04-09 | — | — | EP | claimed |
| JP-2002514208-A | — | — | 2002-05-14 | — | — | JP | claimed |
| WO-2002005799-A2 | COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN | PHARMACIA CORPORATION (US) | 2002-01-24 | — | — | WO | claimed |
| EP-1140181-A1 | COMBINATION THERAPY OF RADIATION AND A COX-2 INHIBITOR FOR THE TREATMENT OF NEOPLASIA | G.D. SEARLE & CO. (US) | 2001-10-10 | — | — | EP | claimed |
| JP-2001505564-A | — | — | 2001-04-24 | — | — | JP | claimed |
| WO-2000038716-A1 | COMBINATION THERAPY OF RADIATION AND A COX-2 INHIBITOR FOR THE TREATMENT OF NEOPLASIA | G.D. SEARLE & CO. (US) | 2000-07-06 | — | — | WO | claimed |
| EP-0971714-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF DEMENTIA | G.D. SEARLE & CO. (US) | 2000-01-19 | — | — | EP | claimed |
| EP-0941080-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1999-09-15 | — | — | EP | claimed |
| WO-1998043648-A1 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF DEMENTIA | G.D. SEARLE & CO. (US) | 1998-10-08 | — | — | WO | claimed |
| WO-1998022101-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1998-05-28 | — | — | WO | claimed |
| EP-1365753-A2 | UROGUANYLIN AND CYCLOOXYGENASE-2 INHIBITOR COMBINATIONS FOR INHIBITION OF INTESTINAL CANCER | Pharmacia Corporation (US) | 2003-12-03 | — | — | EP | disclosed |
| WO-2002062369-A2 | UROGUANYLIN AND CYCLOOXYGENASE-2 INHIBITOR COMBINATIONS FOR INHIBITION OF INTESTINAL CANCER | PHARMACIA CORPORATION (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-0941080-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998022101-A2 | METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS | G.D. SEARLE & CO. (US) | 1998-05-28 | — | — | WO | disclosed |